Looks like they are pushing what they DO have until they get FDA approval for their treatments (or push the treatment/process down another avenue). I'm unsure what's proprietary about the lab suite but perhaps there is a market for it. Maybe someone who's on this board and in the medical community can comment on that. This could be a great source of revenue while the company progresses with their treatment/process.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.